A fundamental need of investigators studying skin disease is to carry out a number of different molecular genetic technologies, including the ability to map, identify, and characterize genes involve in skin differentiation, skin development, skin damage, and skin disease. These analyses require access to specialized high-cost equipment and highly trained personnel with specialized expertise, beyond what is typically available in most individual research laboratories. The objective of the UCD-SDRC Molecular Genetic Analysis Core is to provide investigators with the necessary tools and expertise for both large-scale and smaller-scale, user-defined genotyping of polymorphic genetic markers, large-scale and small-scale DNA sequencing, and for genomewide, multi-gene, and single-gene RNA expression analyses. Each of these technologies requires high-cost items of equipment and expertise, and the UCD-SDRC Molecular Genetic Analysis Core will coordinate access among several existing oncampus core facilities that own and operate the equipment necessary for all of these technologies, to provide these services to UCD-SDCR members at discount pricing compared to either the unsubsidized cost of these services from these core labs or the cost of these services from commercial entities. In addition, the UCD-SDRC Molecular Genetic Analysis Core will provide expertise to investigators in design of genetic studies, so as to optimize use of valuable patient samples and resources to allow investigators to answer important research questions in skin disease.
The UCD-SDRC Molecular Genetic Analysis Core will provide essential infrastructure support to allow members to access a palette of different molecular genetic analytical capabilities not typically found in the ndividual research laboratory. Funds provided to the Core will subsidize SDRC Members'genotyping, DNA sequencing, and gene expression analyses in the investigation of skin disease.
|Mukherjee, Nabanita; Reuland, Steven N; Lu, Yan et al. (2015) Combining a BCL2 inhibitor with the retinoid derivative fenretinide targets melanoma cells including melanoma initiating cells. J Invest Dermatol 135:842-50|
|O'Shea, Charlene; Fitzpatrick, James E; Koch, Peter J (2014) Desmosomal defects in acantholytic squamous cell carcinomas. J Cutan Pathol 41:873-9|
|Luo, Yuchun; Cai, Xiangna; Liu, Sucai et al. (2014) Suppression of antigen-specific adaptive immunity by IL-37 via induction of tolerogenic dendritic cells. Proc Natl Acad Sci U S A 111:15178-83|
|Barón, Anna E; Asdigian, Nancy L; Gonzalez, Victoria et al. (2014) Interactions between ultraviolet light and MC1R and OCA2 variants are determinants of childhood nevus and freckle phenotypes. Cancer Epidemiol Biomarkers Prev 23:2829-39|
|Koch, Peter J; Dinella, Jason; Fete, Mary et al. (2014) Modeling AEC-New approaches to study rare genetic disorders. Am J Med Genet A 164A:2443-54|
|Kogut, Igor; Roop, Dennis R; Bilousova, Ganna (2014) Differentiation of human induced pluripotent stem cells into a keratinocyte lineage. Methods Mol Biol 1195:1-12|
|Bilousova, Ganna; Roop, Dennis R (2014) Induced pluripotent stem cells in dermatology: potentials, advances, and limitations. Cold Spring Harb Perspect Med 4:a015164|
|Riemondy, Kent; Hoefert, Jaimee E; Yi, Rui (2014) Not miR-ly micromanagers: the functions and regulatory networks of microRNAs in mammalian skin. Wiley Interdiscip Rev RNA 5:849-65|
|Deng, Hui; Li, Fulun; Li, Hong et al. (2014) CtBP1 overexpression in keratinocytes perturbs skin homeostasis. J Invest Dermatol 134:1323-31|
|Dinella, Jason; Koster, Maranke I; Koch, Peter J (2014) Use of induced pluripotent stem cells in dermatological research. J Invest Dermatol 134:e23|
Showing the most recent 10 out of 24 publications